South Korea vs United States: Diabetes treatment coverage, crude
South Korea
67.13
in 2022
United States
67.81
in 2022
South Korea rank
15th
United States rank
12th
Diabetes treatment coverage, crude over time
- South Korea
- United States
How they compare
United States currently reports 67.81 against 67.13 in South Korea, a difference of 0.68.
Across all 33 years both countries report, United States has been ahead every year.
South Korea ranks 15th and United States ranks 12th of 198 countries.
United States has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | South Korea | United States | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 38.5 | 54.39 | 15.89 | United States |
| 2000s | 47.44 | 59.74 | 12.3 | United States |
| 2010s | 59.75 | 64.23 | 4.48 | United States |
| 2020s | 66.23 | 67.4 | 1.17 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diabetes treatment coverage, crude, South Korea or United States?
- United States, at 67.81 against 67.13 in South Korea as of 2022.
- What is the difference in diabetes treatment coverage, crude between South Korea and United States?
- 0.68, with United States ahead.
- How many years of comparable data are there for South Korea and United States?
- 33 years are reported by both, from 1990 to 2022.
- How do South Korea and United States rank globally for diabetes treatment coverage, crude?
- South Korea ranks 15th and United States ranks 12th of 198 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diabetes treatment coverage, crude. Statizoid refreshes it automatically from the source and publishes the full history for both places.